Aspire Biopharma Holdings, Inc. Share Price
NASDAQ: ASBP | Micro CapAspire Biopharma Holdings, Inc. Stock Performance
Open $7.60 | Prev. Close $7.89 | Circuit Range N/A |
Day Range $7.43 - $7.91 | Year Range $0.05 - $8.06 | Volume 571 |
Average Traded $7.64 |
Aspire Biopharma Holdings, Inc. Share Price Today
As of 11 August 2026, Aspire Biopharma Holdings, Inc.'s share price is $7.91. The stock opened at $7.60, compared to its previous close of $7.89. During today's trading session, Aspire Biopharma Holdings, Inc.'s share price traded between $7.43 and $7.91, with an average price of $7.67. Over the past 52 weeks, the stock has recorded a high of $8.06 and a low of $0.05. In terms of performance, Aspire Biopharma Holdings, Inc.'s share price has risen by 473.19% over the last six months and is up 1302.48% on a year-on-year basis.
Aspire Biopharma Holdings, Inc. Share Price Chart
Aspire Biopharma Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $11.83M | PE Ratio (TTM) -0.48 | Dividend Yield N/A |
EPS (TTM) $-16.38 | Revenue (TTM) $6202.00 | Return On Equity (TTM) 383.93% |
Profit Margin -394725.06% | Debt to Equity -1.19 | Quarterly Earnings Growth YoY -244.59% |
Aspire Biopharma Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Aspire Biopharma Holdings, Inc. Annual Profit & Loss
All figures in USD
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $7.13 | $7.91 | +21.69% |
Jul 2026 | $5.22 | $6.50 | +26.95% |
Jun 2026 | $5.39 | $5.12 | -5.36% |
May 2026 | $0.21 | $5.41 | +2,359.09% |
Apr 2026 | $0.98 | $0.22 | -77.66% |
Mar 2026 | $1.35 | $0.98 | -28.62% |
Feb 2026 | $1.84 | $1.38 | -35.51% |
Jan 2026 | $0.13 | $2.14 | +1,533.59% |
Dec 2025 | $0.10 | $0.13 | +25.96% |
Nov 2025 | $0.37 | $0.10 | -72.70% |
Oct 2025 | $0.21 | $0.38 | +82.30% |
Sep 2025 | $0.56 | $0.21 | -62.94% |